Feasibility of neoadjuvant transarterial chemoembolization (TACE) using irinotecan beads (DEBIRI) before hepatectomy (HPX) for easily resectable colorectal liver metastases (RCLM): A phase II study.

Graeme Poston,E. O’Grady,H. Malik,Stephen W. Fenwick,M. Terlizzo,Clare Byrne,Myrddin Rees,Juan Figueras,R. Adam

Feasibility of neoadjuvant transarterial chemoembolization (TACE) using irinotecan beads (DEBIRI) before hepatectomy (HPX) for easily resectable colorectal liver metastases (RCLM): A phase II study.

2010

Graeme Poston
E. O’Grady
H. Malik
Stephen W. Fenwick
M. Terlizzo
Clare Byrne
Myrddin Rees
Juan Figueras
R. Adam

3560 Background: Peri-operative chemotherapy confers 3-year disease free survival (DFS) advantage for patients with RCLM. However, studies to date have only examined multiple cycles of systemic neo...

Keywords:

Hepatectomy
General surgery
Phases of clinical research
Medicine
Irinotecan
disease free survival
Oncology
Chemotherapy
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations